Amylyx Pharmaceuticals AMLX
NASDAQ AMLX
$27.79 -0.29 (-1.03%)
At close: Oct 2, 2026 · 4:00 PM EDT

Amylyx Pharmaceuticals (AMLX) Price to Sales (2022 - 2025)

Updated

Amylyx Pharmaceuticals' (AMLX) Price to Sales stood at 392.71 in Q1 2025, compared with 0.49 a year earlier.

Analysis

Amylyx Pharmaceuticals (AMLX) Price to Sales (2022 - 2025) Analysis & Trends

For FY2024, Amylyx Pharmaceuticals' Price to Sales came in at 2.97, up 13.4% from FY2023.

  • Across earlier years, Price to Sales came in at 2.62 in FY2023 (-97.6%) and 110.55 in FY2022.
  • The Q1 2025 figure is the highest quarterly Price to Sales in data going back to Q4 2022.
  • On a year-over-year basis, Price to Sales rose in 1 of the last five quarters, with an average decline of 70.4%.
  • Per Business Quant, the preceding three quarters came in at 2.90 (Q4 2024), 1.12 (Q3 2024) and 0.43 (Q2 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Amylyx Pharmaceuticals 3.13 Bn 3.13 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 392.71
Dec 31, 2024 2.90
Sep 30, 2024 1.12
Jun 30, 2024 0.43
Mar 31, 2024 0.49
Dec 31, 2023 2.62
Sep 30, 2023 4.20
Jun 30, 2023 7.57
Mar 31, 2023 21.02
Dec 31, 2022 109.15
API Access

Amylyx Pharmaceuticals Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=AMLX&period=max&api_key=YOUR_API_KEY